RxDoctor Payments Data

Trisha Shamp

Medical · Minneapolis, MNNPI 1811190226

Payments from drug & device makers

What this record shows

That places this record below the midpoint for medical clinicians in MN, where the typical reported total is $112.

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

$2,499,278in research payments, 2019–2025

Across 67 payments — averaging $37,303 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$791K
  • Roche Diagnostics Operations, Inc.$595K
  • Otsuka Pharmaceutical Development & Commercialization, Inc.$422K
  • Lexicon Pharmaceuticals, Inc.$245K
  • Sanofi$192K
  • Astrazeneca UK Limited$176K
  • plus $78K from 3 others

How this compares

$0 in reported general payments places this provider in the 0th percentile of 202 medical providers in Minnesota.

See all medical providers in Minnesota

Other medical in Minneapolis

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →